|
1
|
Siegel R, Desantis C and Jemal A:
Colorectal cancer statistics, 2014. CA Cancer J Clin. 64:104–117.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Center MM, Jemal A, Smith RA and Ward E:
Worldwide variations in colorectal cancer. CA Cancer J Clin.
59:366–378. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Center MM, Jemal A and Ward E:
International trends in colorectal cancer incidence rates. Cancer
Epidemiol Biomarkers Prev. 18:1688–1694. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Morán A, Ortega P, de Juan C,
Fernández-Marcelo T, Frías C, Sánchez-Pernaute A, Torres AJ,
Díaz-Rubio E, Iniesta P and Benito M: Differential colorectal
carcinogenesis: Molecular basis and clinical relevance. World J
Gastrointest Oncol. 2:151–158. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Andrae J, Gallini R and Betsholtz C: Role
of platelet-derived growth factors in physiology and medicine.
Genes Dev. 22:1276–1312. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li X and Eriksson U: Novel PDGF family
members: PDGF-C and PDGF-D. Cytokine Growth Factor Rev. 14:91–98.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kong D, Banerjee S, Ahmad A, Li Y, Wang Z,
Sethi S and Sarkar FH: Epithelial to mesenchymal transition is
mechanistically linked with stem cell signatures in prostate cancer
cells. PLoS One. 5:e124452010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sethi S, Sarkar FH, Ahmed Q, Bandyopadhyay
S, Nahleh ZA, Semaan A, Sakr W, Munkarah A and Ali-Fehmi R:
Molecular markers of epithelial-to-mesenchymal transition are
associated with tumor aggressiveness in breast carcinoma. Transl
Oncol. 4:222–226. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang Z, Ali S, Banerjee S, Bao B, Li Y,
Azmi AS, Korc M and Sarkar FH: Activated K-Ras and INK4a/Arf
deficiency promote aggressiveness of pancreatic cancer by induction
of EMT consistent with cancer stem cell phenotype. J Cell Physiol.
228:556–562. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wu Q, Hou X, Xia J, Qian X, Miele L,
Sarkar FH and Wang Z: Emerging roles of PDGF-D in EMT progression
during tumorigenesis. Cancer Treat Rev. 39:640–646. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhao L, Zhang C, Liao G and Long J:
RNAi-mediated inhibition of PDGF-D leads to decreased cell growth,
invasion and angiogenesis in the SGC-7901 gastric cancer xenograft
model. Cancer Biol Ther. 9:42–48. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Schläfli AM, Berezowska S, Adams O, Langer
R and Tschan MP: Reliable LC3 and p62 autophagy marker detection in
formalin fixed paraffin embedded human tissue by
immunohistochemistry. Eur J Histochem. 59:24812015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jackson MF, Hoversten KE, Powers JM,
Trobridge GD and Rodgers BD: Genetic manipulation of myoblasts and
a novel primary myosatellite cell culture system: Comparing and
optimizing approaches. FEBS J. 280:827–839. 2013.PubMed/NCBI
|
|
14
|
Yan LH, Wei WY, Cao WL, Zhang XS, Xie YB
and Xiao Q: Overexpression of E2F1 in human gastric carcinoma is
involved in anti-cancer drug resistance. BMC Cancer. 14:9042014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bustin SA, Benes V, Garson JA, Hellemans
J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaffl MW, Shipley GL,
et al: The MIQE guidelines: Minimum information for publication of
quantitative real-time PCR experiments. Clin Chem. 55:611–622.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408, 25. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ahmad A, Wang Z, Kong D, Ali R, Ali S,
Banerjee S and Sarkar FH: Platelet-derived growth factor-D
contributes to aggressiveness of breast cancer cells by
up-regulating Notch and NF-κB signaling pathways. Breast Cancer Res
Treat. 126:15–25. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li H, Tang J, Lei H, Cai P, Zhu H, Li B,
Xu X, Xia Y and Tang W: Decreased MiR-200a/141 suppress cell
migration and proliferation by targeting PTEN in hirschsprung's
disease. Cell Physiol Biochem. 34:543–553. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Stoffel EM: Screening in GI cancers: The
role of genetics. J Clin Oncol. 33:1721–1728. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Grady WM and Markowitz SD: The molecular
pathogenesis of colorectal cancer and its potential application to
colorectal cancer screening. Dig Dis Sci. 60:762–772. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tsujii M: Search for novel target
molecules for the effective treatment or prevention of colorectal
cancer. Digestion. 85:99–102. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang Z, Ahmad A, Li Y, Kong D, Azmi AS,
Banerjee S and Sarkar FH: Emerging roles of PDGF-D signaling
pathway in tumor development and progression. Biochim Biophys Acta.
1806:122–130. 2010.PubMed/NCBI
|
|
24
|
Kong D, Banerjee S, Huang W, Li Y, Wang Z,
Kim HR and Sarkar FH: Mammalian target of rapamycin repression by
3,3′-diindolylmethane inhibits invasion and angiogenesis in
platelet-derived growth factor-D-overexpressing PC3 cells. Cancer
Res. 68:1927–1934. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang Z, Kong D, Li Y and Sarkar FH: PDGF-D
signaling: A novel target in cancer therapy. Curr Drug Targets.
10:38–41. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kong D, Wang Z, Sarkar SH, Li Y, Banerjee
S, Saliganan A, Kim HR, Cher ML and Sarkar FH: Platelet-derived
growth factor-D overexpression contributes to
epithelial-mesenchymal transition of PC3 prostate cancer cells.
Stem Cells. 26:1425–1435. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu J, Liao S, Huang Y, Samuel R, Shi T,
Naxerova K, Huang P, Kamoun W, Jain RK, Fukumura D and Xu L: PDGF-D
improves drug delivery and efficacy via vascular normalization, but
promotes lymphatic metastasis by activating CXCR4 in breast cancer.
Clin Cancer Res. 17:3638–3648. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang Z, Kong D, Banerjee S, Li Y, Adsay
NV, Abbruzzese J and Sarkar FH: Down-regulation of platelet-derived
growth factor-D inhibits cell growth and angiogenesis through
inactivation of Notch-1 and nuclear factor-kappaB signaling. Cancer
Res. 67:11377–11385. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ranganathan P, Weaver KL and Capobianco
AJ: Notch signalling in solid tumours: A little bit of everything
but not all the time. Nat Rev Cancer. 11:338–351. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fraser CC: Exploring the positive and
negative consequences of NF-kappaB inhibition for the treatment of
human disease. Cell Cycle. 5:1160–1163. 2006. View Article : Google Scholar : PubMed/NCBI
|
